✦ LIBER ✦

Enzyme replacement therapy for mucopolysaccharidosis II from 3 months of age: a 3-year follow-up

✍ Scribed by A Tylki- Szymanska; A Jurecka; Z Zuber; A Rozdzynska; J Marucha; B Czartoryska

Book ID: 114817084
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 514 KB
Volume: 101
Category: Article
ISSN: 0803-5253
DOI: 10.1111/j.1651-2227.2011.02385.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enzyme Replacement Therapy in an Attenua

Enzyme Replacement Therapy in an Attenuated Case of Mucopolysaccharidosis Type I (Scheie Syndrome): A 6.5-Year Detailed Follow-Up

✍ Agnieszka Jurecka; Jolanta Marucha; Elżbieta Jurkiewicz; Agnieszka Różdżyńska-Św 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 444 KB

Enzyme replacement therapy for mucopolys

Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age–a sibling control study

✍ JJ McGill; AC Inwood; DJ Coman; ML Lipke; D De Lore; SJ Swiedler; JJ Hopwood 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 600 KB

Biomet Microfixation TMJ Replacement Sys

Biomet Microfixation TMJ Replacement System: A 3-Year Follow-Up Study of Patients Treated From 1995 to 2005

✍ Samuel J. McKenna 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Effects of enzyme replacement therapy on

Effects of enzyme replacement therapy on five patients with advanced late-onset glycogen storage disease type II: a 2-year follow-up study

✍ Yoshihiko Furusawa; Madoka Mori-Yoshimura; Toshiyuki Yamamoto; Chikako Sakamoto; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 295 KB

Efficacy and safety of enzyme replacemen

Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study

✍ Hendriksz, Christian J.; Burton, Barbara; Fleming, Thomas R.; Harmatz, Paul; Hug 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 358 KB

Postsurgical adjuvant therapy for melano

Postsurgical adjuvant therapy for melanoma : Evaluation of a 3-year randomized trial with recombinant interferon-α after 3 and 5 years of follow-up

✍ Luigi Rusciani; Sandra Petraglia; Massimo Alotto; Stefano Calvieri; Giampaolo Ve 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

patients with melanoma. The results obtained with medical therapies are still quite disappointing, with better results observed in soft tissue and lymph node